Abstract
Nuclear medicine (NM) utilizes a variety of unsealed radioactive compounds, known as radiopharmaceuticals or radiotracers. Given in small (tracer) quantities, radiopharmaceuticals typically consist of two components: a radionuclide (also known as a radioisotope) and a molecular or cellular carrier; the latter determines the biologic distribution upon administration to a patient. The most common routes of administration in clinical practice are intravenous (IV) and oral.
Original language | English |
---|---|
Title of host publication | Emergency Radiology |
Subtitle of host publication | Imaging of Acute Pathologies |
Pages | 167-182 |
Number of pages | 16 |
Volume | 9781441995926 |
ISBN (Electronic) | 9781441995926 |
DOIs | |
State | Published - Oct 1 2013 |
Bibliographical note
Publisher Copyright:© 2013 Springer Science+Business Media New York. All rights are reserved.
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology